To attend this session virtually, please click:
One tap mobile: | US: +13126266799,,92063212071# or +16465588656,,92063212071# |
Meeting URL: | https://baystatehealth.zoom.us/j/92063212071?pwd=e5y1yzeEg8SmL6vxwGNiSDTbcvLm0T.1 |
Meeting ID: | 920 6321 2071 |
Passcode: | 823276 |
For questions, please contact Paula Brooks via email at Paula.Brooks@baystatehealth.org
Objectives
After participating in this educational activity, attendees should be able to:
1|Describe the pathophysiology and risk stratification of NSTEMI, including the roles of biomarkers, clinical assessment, and imaging in diagnosis and risk assessment.
2|Review evidence-based management strategies for NSTEMI, with a focus on pharmacologic interventions (e.g., antiplatelet therapy, anticoagulation) and revascularization options, and their impact on patient outcomes.
3|Evaluate the importance of a multidisciplinary approach in the management of NSTEMI, highlighting the roles of cardiologists, nurses, and other healthcare professionals in optimizing care and improving long-term prognosis.
Presenter(s):
Amir Lotfi, MD
Chief of Cardiology
Baystate Medical Center
Professor of Medicine, UMass-Chan
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
---|---|---|---|
Amir Lotfi, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
- 1.00 AAPA Category 1 CME creditBaystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
- 1.00 ACPE Contact Hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 IPCE Credit Hour(s)